Chuong Duong Corp (CDC) Acquires 49% Stake in Trieu Duong for VND 294 Billion
This Aveluro analysis covers CDC on HOSE in the Construction & Materials sector. The classified event type is m a announcement, with neutral sentiment and a deterministic market-impact score of 5.6/10. Source coverage came from CafeF - Doanh nghiệp, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
Chuong Duong Corp (HOSE: CDC) announced that its board of directors approved a plan to acquire a 49% stake in Công ty CP Thương mại Đầu tư và Phát triển Triều Dương (Trieu Duong Company) for an estimated VND 294 billion. The transaction would make CDC the largest shareholder of the target, a Hồ Chí Minh City-based real estate company. The resolution was disclosed via a board resolution published by the company.
Key Facts
- CDC’s board approved the acquisition of 49% of Trieu Duong Company, with a provisional transaction value of VND 294 billion.
- The official transfer price will not exceed that figure and will be set based on an independent valuation.
- Trieu Duong Company has charter capital of VND 600 billion and was established on 30 September 2026.
- Its registered office is at 523 Phạm Văn Đồng, Bình Lợi Trung Ward, Hồ Chí Minh City.
- Founding shareholders were Delta Trade Investment and Development Co. (15%), Nguyễn Khánh Hoàng (1%) and Nguyễn Hải Nam (84%).
- The board delegated Chairman Nguyễn Ngọc Bền and CEO Văn Minh Hoàng to run legal, financial and independent valuation due diligence, negotiate and sign the share transfer contract and shareholders’ agreement, and appoint CDC’s representatives at Trieu Duong.
- CDC last closed at 20,700 on 1 October 2026.
What Happened
According to the board resolution, Chuong Duong Corp approved in principle the receipt of a 49% equity interest in Trieu Duong Company. The provisional consideration is VND 294 billion, with the final transfer price capped at that amount and to be determined from an independent appraisal. On completion, CDC would become the largest shareholder of Trieu Duong.
The resolution authorises Chairman Nguyễn Ngọc Bền, who is also the legal representative, and CEO Văn Minh Hoàng to carry out legal, financial and valuation due diligence, set the official transfer price, negotiate and execute the share transfer contract, the shareholders’ agreement and related documents, and appoint representatives to manage CDC’s capital contribution at Trieu Duong. Trieu Duong was incorporated on 30 September 2026 with charter capital of VND 600 billion, focused on real estate trading and land-use rights. Its founding shareholders were Delta Trade Investment and Development Co. at 15%, Nguyễn Khánh Hoàng at 1% and Nguyễn Hải Nam at 84%. Nguyễn Khánh Hoàng is the target’s CEO and legal representative, while Nguyễn Hải Nam also serves as CEO, legal representative and 43.143% shareholder of Delta.
Market Context
CDC trades on the HOSE and closed at 20,700 on 1 October 2026. The company sits in the construction and materials industry group, while the acquisition targets a real estate vehicle, extending CDC’s exposure toward property development. The deal is small in absolute terms relative to the Vietnamese market’s largest M&A transactions, but it is material for a company of CDC’s size and comes as domestic real estate credit and land-use policy remain key swing factors for Hồ Chí Minh City property developers.
Strategic Significance
The transaction gives CDC control-level influence over a newly incorporated real estate platform with VND 600 billion in charter capital, at a provisional price that values the 49% stake at VND 294 billion. For long-term investors, the key question is whether CDC is buying into a pipeline of land or projects held by the founding shareholders, particularly Nguyễn Hải Nam, whose interests span both Trieu Duong and Delta. The structure, a minority stake paired with a shareholders’ agreement and board representation, suggests CDC intends operational influence rather than a passive financial holding. Execution risk rests on the independent valuation and on how the shareholders’ agreement allocates control.
What to Watch
- Disclosure of the official transfer price following the independent valuation.
- Signing of the share transfer contract and shareholders’ agreement, and the appointment of CDC’s representatives at Trieu Duong.
- Details of Trieu Duong’s land bank, projects or assets, which the resolution does not disclose.
- Any related-party disclosure involving Nguyễn Hải Nam, Delta or CDC’s own shareholders.
- CDC’s next financial statements for the capital commitment and any consolidation treatment.